Is MBXBF or NOBL a better dividend investment in 2026?

MBXBF currently yields 1162.79% with a 5% 5-year dividend growth rate. NOBL yields 4.00% with 5% growth. The better choice depends on your goal: MBXBF offers higher current income.

What is the dividend yield difference between MBXBF and NOBL?

MBXBF has a forward dividend yield of 1162.79% ($2.00/share annually). NOBL yields 4.00% ($2.00/share annually). The yield gap is 1158.79 percentage points.

Home › Compare › MBXBF vs NOBL

MBXBF vs NOBL: Dividend Comparison 2026

MBXBF yields 1162.79% · NOBL yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MBXBF wins by $71037548.32M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MBXBF

● Live price

1162.79%

Share price

$0.17

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$71037548.35M

Annual income

$60,758,695,090,499.19

Full MBXBF calculator →

NOBL

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full NOBL calculator →

Portfolio growth — MBXBF vs NOBL

📍 MBXBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MBXBF	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MBXBF + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MBXBF pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MBXBF

Annual income on $10K today (after 15% tax)

$98,837.21/yr

After 10yr DRIP, annual income (after tax)

$51,644,890,826,924.31/yr

NOBL

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, MBXBF beats the other by $51,644,890,826,159.99/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MBXBF + NOBL for your $10,000?

MBXBF: 50%NOBL: 50%

100% NOBL50/50100% MBXBF

Portfolio after 10yr

$35518774.19M

Annual income

$30,379,347,545,699.20/yr

Blended yield

85.53%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MBXBF buys

NOBL buys

No recent congressional trades found for MBXBF or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMBXBFNOBL

Forward yield	1162.79% ✓	4.00%
Annual dividend / share	$2.00	$2.00
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	0%	5% ✓
Portfolio after 10y	$71037548.35M ✓	$28.0K
Annual income after 10y	$60,758,695,090,499.19 ✓	$899.19
Total dividends collected	$70267668.95M ✓	$6.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: MBXBF vs NOBL ($10,000, DRIP)

Year	MBXBF Portfolio	MBXBF Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$126,979	$116,279.07	$11,120	$420.00	+$115.9K → MBXBF
2	$1,515,775	$1,379,907.30	$12,357	$458.31	+$1.50M → MBXBF
3	$17,016,490	$15,394,610.53	$13,721	$499.76	+$17.00M → MBXBF
4	$179,725,369	$161,517,725.51	$15,227	$544.58	+$179.71M → MBXBF
5	$1,786,627,353	$1,594,321,207.48	$16,885	$593.02	+$1786.61M → MBXBF
6	$16,723,791,389	$14,812,100,121.30	$18,713	$645.34	+$16723.77M → MBXBF
7	$147,473,158,468	$129,578,701,682.00	$20,724	$701.81	+$147473.14M → MBXBF
8	$1,225,690,132,710	$1,067,893,853,149.49	$22,938	$762.73	+$1225690.11M → MBXBF
9	$9,606,404,914,243	$8,294,916,472,243.00	$25,372	$828.41	+$9606404.89M → MBXBF
10	$71,037,548,348,739	$60,758,695,090,499.19	$28,047	$899.19	+$71037548.32M → MBXBF

MBXBF vs NOBL: Complete Analysis 2026

MBXBF — Stock

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment and proficiency (QAPs) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to stabilize patient samples for lab-based testing and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. It sells QAPs to lab accreditation organizations, diagnostics companies, and clinical labs through a network of regional distributors. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Full MBXBF Calculator →

NOBL — ETF

NOBL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in NOBL shares.

Full NOBL Calculator →

📬

Get this MBXBF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MBXBF vs SCHD MBXBF vs JEPI MBXBF vs O MBXBF vs KO MBXBF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.